Home

Personalis, Inc. - Common Stock (PSNL)

6.3700
-0.5500 (-7.95%)
NASDAQ · Last Trade: Jul 12th, 11:07 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Cramer Says Tesla Dominates While Ouster Is 'Too Speculative'benzinga.com
Jim Cramer advises against investing in Tempus AI due to its ongoing losses and suggests Pan American as a profitable alternative. Insmed is also considered speculative while the only viable option for autonomous vehicles is Tesla. Ouster's stock was downgraded and other companies experienced mixed price action.
Via Benzinga · July 10, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · July 9, 2025
What's going on in today's after hours sessionchartmill.com
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · July 9, 2025
Earnings Scheduled For May 6, 2025benzinga.com
Via Benzinga · May 6, 2025
A Glimpse Into The Expert Outlook On Personalis Through 7 Analystsbenzinga.com
Via Benzinga · February 28, 2025
Earnings Scheduled For February 27, 2025benzinga.com
Via Benzinga · February 27, 2025
Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)benzinga.com
Via Benzinga · January 27, 2025
Key Takeaways From Personalis Analyst Ratingsbenzinga.com
Via Benzinga · November 7, 2024
Analyst Expectations For Personalis's Futurebenzinga.com
Via Benzinga · May 7, 2025
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.investors.com
A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.
Via Investor's Business Daily · April 17, 2025
What 5 Analyst Ratings Have To Say About Personalisbenzinga.com
Via Benzinga · April 10, 2025
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga.com
Via Benzinga · March 17, 2025
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dipbenzinga.com
Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.
Via Benzinga · March 8, 2025
What Analysts Are Saying About Personalis Stockbenzinga.com
Via Benzinga · November 7, 2024
Assessing Personalis: Insights From 4 Financial Analystsbenzinga.com
Via Benzinga · August 19, 2024
Breaking Down Personalis: 4 Analysts Share Their Viewsbenzinga.com
Via Benzinga · June 21, 2024
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · February 14, 2025
Dow Surges Over 600 Points, Gold Jumps 1.5%benzinga.com
Via Benzinga · December 20, 2024
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higherbenzinga.com
Via Benzinga · December 20, 2024
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · December 20, 2024
Stock Of The Day: Where Does The Merck Downtrend End?benzinga.com
Shares of Merck & Co (MRK) continue to trend lower. If they reach the $95.00 level, there is a good chance they find support and reverse.
Via Benzinga · December 19, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · November 7, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 7, 2024
Why Tempus AI Stock Skyrocketed Nearly 22% Todayfool.com
It deepened its involvement in a client and peer.
Via The Motley Fool · August 21, 2024
PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q2 2024investorplace.com
PSNL stock results show that Personalis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024